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Abstract 
Background: Nigeria has the largest number of malaria-related deaths, accounting for a third of global malaria 
deaths. It is important that the country attains universal coverage of key malaria interventions, one of which is the 
policy of universal testing before treatment, which the country has recently adopted. However, there is a dearth of 
data on its implementation in formal private health facilities, where close to a third of the population seek health care. 
This study identified the level of use of malaria rapid diagnostic testing (RDT), compliance with test results and associ-
ated challenges in the formal private health facilities in Nigeria.
Methods: A cross-sectional study that involved a multi-stage, random sampling of 240 formal private health facili-
ties from the country’s six geo-political zones was conducted from July to August 2014. Data were collected using 
health facility records, healthcare workers’ interviews and an exit survey of febrile patients seen at the facilities, in order 
to determine fever prevalence, level of testing of febrile patience, compliance with test results, and health workers’ 
perceptions to RDT use.
Results: Data from the 201 health facilities analysed indicated a fever prevalence of 38.5 % (112,521/292,430). Of the 
2077 exit interviews for febrile patients, malaria testing was ordered in 73.8 % (95 % CI 71.7–75.7 %). Among the 1270 
tested, 61.8 % (719/1270) were tested with microscopy and 38.2 % (445/1270) with RDT. Compliance to malaria test 
result [administering arteminisin-based combination therapy (ACT) to positive patients and withholding ACT from 
negative patients] was 80.9 % (95 % CI 78.7–83 %). Compliance was not influenced by the age of patients or type of 
malaria test. The health facilities have various cadres of the health workers knowledgeable on RDT with 70 % knowing 
the meaning, while 84.5 % knew what it assesses. However, there was clearly a preference for microscopy as only 20 % 
reported performing only RDT.
Conclusion: In formal private health facilities in Nigeria there is a high rate of malaria testing for febrile patients, high 
level of compliance with test results but relatively low level of RDT utilization. This calls for improved engagement of 
the formal private health sector with a view to achieving universal coverage targets on malaria testing.
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Background
Malaria remains a major public health problem with over 
3.2 billion of the world’s population at risk, of which 1.2 
billion people are at high risk [1, 2]. Over the last 15 years 
there has been concerted effort through global partner-
ships to mobilize resources for the deployment of cost-
effective tools towards a significant reduction in malaria 
morbidity and mortality, with a decrease in malaria 
incidence by 30 % globally, and by 34 % in Africa [2–5]. 
Furthermore, the prevalence of malaria parasite infec-
tion (including both symptomatic and asymptomatic 
infections) fell from 173 million in 2000 to 128 million in 
2013, a reduction of 26 % in Africa [2]. These reductions 
are largely due to increased deployment of long-lasting, 
insecticide-treated nets (LLINs), increased availability 
of highly effective artemisinin-based combination treat-
ment (ACT) and improved diagnosis of malaria. While 
deployment of LLINs and ACT have been significantly 
scaled up towards universal coverage levels in most coun-
tries, scale up of malaria diagnosis has been much slower, 
due to its greater dependence on a number of systemic 
issues influencing availability and usage in guiding anti-
malarial prescriptions.
In 2010 the WHO recommended universal testing 
before treatment in suspected cases of malaria [6, 7]. 
Implementing this requires expanded access to malaria 
diagnosis at all levels and sectors of health care delivery. 
The options for expanding access are scaling up micros-
copy and the use of malaria rapid diagnostic tests (RDTs). 
Malaria microscopy has inherent challenges as a primary 
tool for scaling up diagnosis. These challenges include 
quality control issues, supportive infrastructure, cost and 
manpower capacity needs [8–13]. The RDTs on the other 
hand, while not a substitute for microscopy, possess qual-
ities that address many of the limitations of microscopy. 
This makes the use of RDT a more feasible strategy for 
expanding access to diagnosis [14–18]. Although, use 
of RDT has its own challenges e.g. use of excess buffer/
inappropriate sample well, storage-related challenges but 
they are easily overcome with training and routine super-
vision. Several recent studies have continued to validate 
the usefulness and reliability of RDTs for malaria diagno-
sis in both children and adults [19–24]. The acceptability 
of RDT among care-seekers attending public healthcare 
facilities, patent medicine vendors and private health 
retailers has also been documented by research [25–32]. 
In addition, use of RDTs for malaria diagnosis have been 
reported to be cost-effective in the treatment of malaria, 
especially in relation to the cost of ACT and in the face of 
declining prevalence of malaria [11, 33–37].
Consistent with WHO recommendation, Nigeria, in 
2011, updated the National Malaria Treatment Guide-
lines to reflect universal testing before treatment for 
suspected cases of malaria [29]. Prior to this, the policy 
in Nigeria recommended testing before treatment in chil-
dren older than 5 years and in adults, with a more liberal 
bent for presumptive or syndromic treatment in chil-
dren under 5 years. One of the objectives of the National 
Malaria Strategic Plan 2014–2020 is to test all care-
seeking persons with suspected malaria using RDT or 
microscopy by 2020 [30]. Attaining this objective makes 
it imperative for all levels and segments of the Nigerian 
health system to have access to, and appropriately utilize, 
malaria diagnostic tools. To this end the national malaria 
elimination programme (NMEP) commissioned imple-
mentation research to guide RDT scale-up and deploy-
ment to primary healthcare facilities in the public sector 
[38].
The private health sector in Nigeria is very large, con-
sisting of formal tertiary, secondary and primary health 
facilities, pharmacies and informal drug retailers. The 
National Health Directory listed 34,173 health facilities 
in Nigeria at December 2011 [39]. This has been updated 
recently to 34,423 health facilities in the country [40]. 
Forty per cent of these registered health facilities belong 
to the private sector, especially at primary and secondary 
health care level [39]. Regarding health-seeking behav-
iour, about 60 % of people seek treatment for fever from 
private health facilities while 40 % go to the public sector 
[41]. Key implementing partners involved with malaria 
case management (including training on microscopy and 
RDT use) in the private health sector in Nigeria include 
the society for family health (SFH), DfID funded support 
for national malaria programme (SuNMaP) and PMI-
funded malaria action programme for states (MAPS). 
The UNITAID is currently working on RDT roll-out to 
the private sector.
Studies have indicated the inherent differences in 
healthcare practices across the different health sectors 
(private vs public) and even within the same sector [42–
45]. Considering that the formal private health facilities 
are a major contributor to healthcare delivery in Nigeria, 
their compliance with national policies and treatment 
guidelines is critical to attainment of the overall goal of 
the NMEP. The independence by clients in dictating their 
service needs and overall mode of engagement of the for-
mal private health sector, that is profit driven, precludes 
any extrapolation of data from the public sector to the 
formal private health sector.
In light of the dearth of knowledge on the status of 
RDT use in the formal private health sector in Nigeria, 
this study was undertaken to identify practices related to 
the use of RDT in private health facilities. With lessons 
learnt from the surveys in the public health sector and 
informal private sector, it was expected that the findings 
from this study on formal private health facilities would 
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complete the loop of understanding needed to guide 
continued deployment and use of RDTs in the country. 
Improved diagnosis will contribute to better treatment 
of malaria, thereby contributing further to reduction in 
malaria mortality and better tracking of progress made.
Methods
This was a cross-sectional study to assess RDT use and 
its associated challenges in formal private health facilities 
in Nigeria. Formal private health facilities were defined 
as hospitals, clinics or maternity homes registered by the 
state ministry of health (SMOH) as a private health facil-
ity offering orthodox medical care. This excludes health 
facilities registered primarily as pharmacy/patent and 
proprietary medicine vendors and/or for laboratory ser-
vices. State Hospital Management Boards register, regu-
late and license private health facilities. For the purpose 
of this study, only private hospitals were enrolled.
Study sites
Nigeria is a West African country with 36 states and 
774 Local Government Areas (LGAs) and Federal Capi-
tal Territory (FCT). For administrative convenience 
and representation, the country uses geo-political zon-
ing, comprising northcentral (six states and the FCT); 
northeast (six states); northwest (six states); southeast 
(five states); southsouth (six states and southwest (six 
states). Malaria transmission has been intense, stable 
and holo-endemic in most parts of the country. Recent 
reports suggest some changes over time, such that as at 
2010, 85 % of Nigerians lived in areas supporting meso-
endemic transmission, 15  % lived under conditions of 
hyper-holo-endemicity, with some areas within FCT and 
northeastern states supporting hypo-endemicity [46]. 
Seasonality, intensity and duration of malaria transmis-
sion in Nigeria varies according to five ecological strata. 
These include mangrove swamps, rain forest, guinea-
savannah, sudan-savannah and sahel-savannah. The 
duration of the season decreases from the south to the 
north, being perennial in duration in most of the south 
but lasting 3 months or less in the northeastern region 
bordering Chad [47]. In the north, high transmission 
season is between July and November and in the south 
is between April and October with bimodal peaks in July 
and September.
Study setting
The study was designed to determine the prevalence of 
fever, the practices related to RDT use, and to understand 
the perception of a sample of health workers to RDT. It 
was anticipated that there could be significant variations 
in the quality of health facility records, thereby limiting 
their aggregation to answer the research questions. 
Three sets of tools were designed to address the study 
objectives:
Health facility records: this was to focus on the record 
of illness episodes as documented in order to establish 
the proportion of complaints that were fever. The facil-
ity interview focused on attendance rate and propor-
tion of fever cases over the preceding 6 months of the 
study. Information on the facility stock level, utilization 
of malaria commodities, supply chain management sys-
tem, state of infrastructure and challenges encountered 
was also captured in the questionnaires. The records 
were extracted from National Health Management Infor-
mation registers provided with support from the Global 
Fund through SFH or any other hospital register where 
these were not available.
Healthcare workers’ interviews conducted to appraise 
the practices of the health facilities as reported by the 
health workers. Data were collected from the officers-in-
charge or health personnel that dispense diagnostics.
Exit interview of febrile patients: aimed at systemati-
cally and prospectively collating perceptions of patients 
regarding RDT at the private health facilities. In addition, 
it was expected to provide a reliable denominator to facil-
itate the estimates related to level of diagnosis and com-
pliance with test results.
Sampling technique
The health facilities were selected using a multi-staged, 
random sampling technique. In the first stage, six states 
were randomly selected using geo-political zones as sam-
pling frames viz; Cross-River in mangrove ecological 
zone, Enugu and Lagos in rain forest, Kaduna in sudan-
savannah), Kwara and Ogun in guinea-savannah. States 
in the northeast geo-political zone were excluded on 
account of security reasons, and Lagos State was selected 
because of its coastal location and status as emerging 
mega city. In each selected state, two LGAs (one urban 
and one rural) were randomly selected. From each of 
the selected LGAs, the health facilities were selected by 
simple random sampling from a sampling frame of the 
list of registered private health facilities obtained from 
the SMOH. Twenty private health facilities were selected 
from each LGA. In cases where there were less than 20 
private health facilities available in a selected LGA, data 
were collected from health facilities in a contiguous LGA 
to complete the sample size. Thus, data were collected 
from a total of 240 private health facilities across the 
country (Fig. 1). One health facility survey questionnaire, 
one health worker interview questionnaire and ten exit 
interviews per facility was administered across health 
facilities surveyed.
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Study procedure
Preliminary activities consisted of meetings between the 
Principal Investigator (PI), State team leaders and other 
key members of the study team to fine-tune the data 
capture tools and data analysis methods. Data collection 
tools comprised questionnaires to capture previous med-
ical records, to ascertain hospital attendance and propor-
tion of febrile patients tested and treated appropriately, 
and exit interview questionnaires to validate reported 
practice and community perception of RDT. The ques-
tionnaires were pre-tested in health facilities in the Fed-
eral capital city where the study would not be carried out 
and observations made during the pilot informed revi-
sion of the final data capture tools.
At each study site, the study team comprised the team 
leader, six interviewers, the state epidemiologist, state 
malaria programme officer and malaria focal persons at 
the two LGAs. Field statisticians were assigned, one each, 
by NMEP to various study sites. A two-day training work-
shop was organized at each site prior to commencement 
of field work. During the workshops, the state team 
members were familiarized with the objectives of the 
study and introduced to the data capture tools. Ethical 
clearance for the study was obtained from the National 
Health Research and Ethics Committee (NHREC).
Data collection
Data were collected using study instruments over 22 days 
in each state from July to August 2014. Data collected 
were reviewed and cleaned each day by the state team 
leaders and field statisticians, who subsequently entered 
data in computer. At the end of data collection in each 
state, the field statisticians sent their data set to the cen-
tral study statistician for pooled entry.
Data management
Data entry was done using EPI info version 3.5.4. There 
was onsite data entry by each of the team data man-
agement officers. Thereafter, data from the states were 
merged to create a common database. Simple frequencies 
* No state from North East, Lagos selected instead
36 states of the Federation plus FCT
Grouped into 6 geopolitical zones 
North East* 
with 6 states 
North West
with 7 states 
North Central
with 6 states 
South South
with 6 states 
South West 
with 6 states 
South East


































20 Health Facilities per LGA (40 HF per 
State) 
240 Health Facilities across the 
Country 
Fig. 1 Flow chart on sampling procedure
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were generated to facilitate the process of data cleaning. 
Queries were generated and clarifications sought from 
the respective teams as applicable. The cleaned data-
set was subsequently exported to SPSS version 22 for 
analysis.
Frequency tables and charts were used to present sim-
ple proportions with 95 % confidence intervals (CI) using 
the online Vassarstat® application. Comparison of cat-
egorical variables and specific outcome was carried out 
using the Chi square test, while the comparison between 
continuous variables and specific discrete outcomes was 
done by Student t test. For all the statistical analysis, the 
level of significance was set at p < 0.05, 95 % CI.
Limitation
This study did not address quality assurance of malaria 
diagnostics in the private sector. Record keeping was gen-
erally poor precluding a comparison of the data extracted 
from the registers among the study sites. The decision to 
use mainly the exit survey in defining denominators for 
the various measurements was informed by the anticipa-
tion of this possibility.
Results
The study was conducted using three instruments: sum-
mary of medical records, exit interviews and key health 
staff interviews. The flow of data collection is summa-
rized in Fig. 2. Of the 232 facilities with health workers’ 
responses to malaria testing practices, microscopy was 
done in 98 (42.2 %) health facilities, RDT in 46 (19.8 %), 
both RDT and microscopy in 74 (31.8 %), while 16 (6.8 %) 
reported that they do not carry out any malaria test in the 
facility. Of the 240 health facilities, 107 (44.6 %) currently 
had RDT in stock though 110 (45.8 %) use RDT routinely.
Prevalence of fever from health facilities
Data of hospital registers from 240 healthcare facilities 















Included per protocol 
(N=2077)
Tested for malaria 
(N=1533)
Tested for malaria and 
knew result,analysed for 
compliance (N=1259)
Not submied for 
analysis - not tested 
for malaria (N=544)
Excluded - not eligible 
for exit interview 
(N=317)
Health facility staff 
interviewed
(N=240)
Included per protocol 
and submied for 
analsis (N=240)
Fig. 2 Description of algorithm for data collection and enrolment of subjects
Page 6 of 11Mokuolu et al. Malar J  (2016) 15:4 
hospital consultations; 39 incomplete records (Kwara: 27, 
Kaduna: 7, Cross-River: 3 and Ogun: 2) were excluded; 
data were analysed for 201 health facilities (Fig.  2). The 
prevalence of fever in relation to total attendance at the 
health facilities was 38.5 % (112,521/292,430) within the 
period of 6 months (January–June 2014) (Table 1).
Health facility practices from exit interviews
Concomitant symptoms: A total of 2077 exit interviews 
were conducted for febrile patients across the study 
sites (Fig.  2). In addition to fever, generalized weakness 
(60.9  %), cough/catarrh (44.5  %), vomiting/diarrhoea 
(39.9  %), pallor (8.1  %) and convulsion (1.3  %) were 
reported as presenting symptoms (Table  2). The distri-
bution of these symptoms was similar across the sites 
(Table 2).
Use of malaria diagnostics: Out of the 2077 febrile 
patients, 1533 had their blood tested during the hospi-
tal visit (Fig. 2), giving a testing rate of 73.8 % (95 % CI 
71.7–75.7  %) for febrile patients visiting the formal pri-
vate health facilities. Out of the 1533 patients who had 
their blood tested, 1259 (82.1 %) were told the outcome 
of the test carried out. Among those tested 1164 (75.9 %) 
knew the type of test carried out (microscopy or RDT). 
Of those that knew the test type, 719/1164 (61.8 %) were 
tested with microscopy, while 445 (38.2  %) were tested 
with RDT. Of the patients who knew the outcome of their 
tests, 1079 (85.7  %) were positive for malaria while 180 
(14.3  %) were negative. Among respondents who pro-
vided information on payment for these laboratory ser-
vices, 90.1  % of them reported that they paid for their 
blood test out of which 53.7 % knew the amount paid.
Reported compliance with test results: Compliance 
was computed from the total of those positive for malaria 
that had ACT and those negative for malaria that did not 
receive ACT/anti-malarial expressed as a proportion of 
the total tested. Findings in this regard showed that of 
1078 patients whose malaria test results were reported 
positive, 892 (82.7  %) received ACT while out of 181 
patients whose malaria tests were reported as negative, 
126 (69.6  %) did not receive ACT. Thus, ‘compliance’ 
to malaria test result in administering ACT was 80.9  % 
(95  % CI 78.7–83.0  %). The compliance was 75  % in 
Enugu and consistently above 80 % in all the other states 
with Kwara having the highest at 87 % (Table 3). Stratify-
ing the reported compliance practices by the type of test 
performed and by age (<5 vs 5 years and above) indicated 
that there were no apparent differences in the compliance 
patterns on the basis of these parameters (Table 4).
Health facility practices from health workers’ in‑depth 
interviews
Two-hundred and forty health workers were interviewed 
in order to triangulate their information with what was 
obtained in the exit interviews so as to understand prac-
tices within the health facilities in relation to malaria 
diagnosis and treatment. The distribution of respondents 
shows that the majority were doctors 69 (29.1  %), fol-
lowed by nurses 51 (21.5  %), medical laboratory scien-
tists 50 (21.1 %), auxiliary nurses 31 (13.1 %), community 
health extension workers 26 (11.0 %), community health 
Table 1 Record of  attendance in  sampled formal private 
health facilities in Nigeria
a Data was incomplete in some states
State (no of HF)a Total attend‑
ance
Total fever Percentage 
with fever
Cross River state 
(n = 37)
17,745 8374 47
Enugu (n = 40) 73,670 29,924 41
Kaduna (n = 33) 65,879 29,317 45
Kwara (n = 13) 39,292 11,078 28
Lagos (n = 39) 47,506 16,904 36
Ogun (n = 38) 48,338 16,924 35
Total (n = 200) 292,430 112,521 38.5
Table 2 Frequency of complaints among 2077 respondents with fever by study sites
Multiple symptoms
State Fever Concomitant symptoms
General weakness Cough catarrh Diarrhoea vomiting Convulsions Pallor
C/River 344 258 210 120 10 3
Enugu 385 181 223 154 7 19
Kaduna 398 211 140 170 0 19
Kwara 375 245 152 170 6 18
Lagos 327 268 149 134 1 49
Ogun 248 101 109 132 4 71
Total 2077 1264 (60.9) 983 (44.5) 880 (39.9) 28 (1.3) 179 (8.1)
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workers 7 (3.0 %) while pharmacists, 3 (1.3 %), were least 
represented.
Health facilities with knowledgeable health workers: 
Among the 240 health workers, 70.0 % knew the mean-
ing of RDT, while 84.5  % knew what RDT assesses. Of 
the 229 that responded to the question on specimen used 
for RDT, 210 (91.7 %) knew that blood was used for the 
test, one (0.4 %) said urine was used for the test while 18 
(7.9 %) did not know the specimen used for the test. Of 
the 223 respondents to the question on how to carry out 
RDTs, 160 (71.7 %) knew how to carry out RDT while 63 
(28.3 %) did not know. Practices of health workers were 
equally assessed. In 87.8 % (95 % CI 82–92 %) of health 
workers, results of RDT were available at the time of 
treating patient. The result of RDT was used in 73.7  % 
(95  % CI 67–79  %) to determine treatment. Reported 
mean time for performing RDT was 11.9 [standard devia-
tion (SD) 7.7] minutes. The mean amount paid for the test 
was N375 (SD 175), an equivalent of $2.5 as at the time 
of the study. Perception-wise: 75 % (95 % CI 73–85 %) of 
health workers were of the opinion that RDT was use-
ful in their facilities. In addition, the majority reported it 
took a short time, was easy to conduct, and that it did not 
interfere with clinic activities (Table 5).
Discussion
Fever prevalence from the health facilities’ records was 
38.5  %. The prevalence varied from 28 to 47  % across 
the various geo-political zones of the country. The fever 
prevalence in this study is lower than previously reported 
rate of 60  % among outpatients [29]. It is also slightly 
lower than the weighted average of 43 and 45 % reported 
among children taken to formal hospitals in northeastern 
and southern parts of the country, respectively [48]. The 
reasons for this lowering in fever prevalence may be con-
nected to overall reductions and gains made in the con-
trol of malaria and acute respiratory tract infections [2, 
46]. However, an additional possibility is that there is a 
wider range of non-febrile conditions that may be seen 
at the formal private health facilities since most users 
of such facilities tend to subscribe as families and they 
report there as their primary point of call for a variety of 
non-febrile conditions.
Among the 2077 patients with fever, there were a num-
ber of concomitant symptoms. The most frequent being 
generalized weakness, cough, vomiting, and diarrhoea. 
The predictive importance of the individual symptoms 
in relation to malaria was not undertaken in this study. 
However, the combination of these features continues to 
underscore the challenge of developing a reliable clinical 
Table 3 Compliance with use of ACTs








C/River 262 191 19 80.2
Enugu 203 134 18 74.9
Kaduna 293 214 34 84.6
Kwara 177 143 11 87.0
Lagos 187 118 27 77.5
Ogun 138 92 17 79.0
Total 1259 892 126 80.9
Table 4 Malaria Test result and ACT use
Selection n ACT given Chi square P‑value Compliance (95 % CI)
Yes (%) No (%)
All tests 1259 <0.0001 80.9 (78.7–83.0)
 Positive 892 (82.7) 186 (17.3)
 Negative 55 (30.4) 126 (69.6)
Microscopy only 633 <0.0001 83.1 (80.0–85.8)
 Positive 484 (85.7) 81 (14.3)
 Negative 26 (38.2 %) 42 (61.8 %)
mRDT only 412 <0.0001 85.7 (82.0–88.7)
 Positive 291 (88.7) 37 (11.3)
 Negative 22 (26.2) 62 (73.8)
Under 5 117 <0.0001 79.5 (71.3–85.8)
 Positive 84 (79.2) 22 (20.8)
 Negative 2 (18.2) 9 (81.8)
5-years & above 1081 <0.0001 80.9 (78.4–83.1)
 Positive 760 (82.8) 158 (17.2)
 Negative 49 (30.1) 114 (89.9)
Page 8 of 11Mokuolu et al. Malar J  (2016) 15:4 
algorithm for the diagnosis of malaria. Most efforts in 
this regard have resulted in relatively poor sensitivity and 
specificity, making the diagnosis of malaria solely reli-
ant on parasitological testing [49–51]. This was the basis 
of Nigeria’s recent policy change, in alignment with the 
global recommendation on testing before treatment, 
that until proven by test, a case of fever regardless of the 
clinical symptomatology, is ‘suspected’ malaria [52]. This 
study’s finding on the status of the implementation of the 
‘test before treatment’ strategy in a national survey of pri-
vate health facilities is therefore instructive.
This study showed that about three-quarters, 73.8  % 
(95  % CI 71.9–75.7  %) of fever cases were tested for 
malaria in private health facilities in Nigeria. This is much 
higher than testing rates reported in public health facili-
ties in the country [38]. The 2013 Nigeria Demographic 
and Health Survey (NDHS) reported that only 11.1 % of 
children under 5 years with fever had blood taken for 
testing [41]. The finding could be considered counter-
intuitive when it is considered that unlike public facilities, 
private facilities, which are classified under ‘alterna-
tive healthcare system’ in Nigeria’s three-tier structure 
(National Health Policy), are less supervised for qual-
ity of care and adherence to guidelines. Conversely, this 
finding is comforting, given the fact that more Nigerians 
seek care for fever in private health facilities despite the 
relatively larger size of the public health sector [39, 41]. It 
perhaps lends some support to the underrated successes 
of the country’s decade-old Roll Back Malaria campaign 
aimed at achieving universal coverage of malaria inter-
ventions. It also probably reflects the support from RBM 
partners and the Global Fund to malaria case manage-
ment in the private sector.
A further possible reason for the high testing rate in 
private health facilities could be motivation for income 
generation, fear of litigation or simply an adherence to 
policy/practice regulation. Anecdotal evidence in infor-
mal medical discourse in Nigeria favours the notion that, 
because of economic gain, private practitioners are ‘quick 
on the draw’ to order tests for care-seekers. That said, 
the outcome of this study regarding the status of testing 
for malaria before treatment in private health facilities is 
commendable.
Testing with RDTs was not observed to be as common 
as testing by microscopy, which, although considered the 
gold standard, requires more stringent conditions [14, 
53, 54]. This appears consistent with some other studies 
where it has been observed that availability of RDTs was 
limited in a sample of private facilities that were studied 
[55]. This is probably because formal private facilities 
are expected to be less resource-constrained than public 
facilities, even in low- and middle-income countries such 
as Nigeria, owing to their ‘for-profit’ orientation. There 
may also be concerns that the quality of RDTs could limit 
their preference in the private health facilities [55]. Con-
cerns about quality may have been why the double test of 
RDT and microscopy, was performed. The recent scale-
up of RDT deployment in the NMEP has been largely 
directed at the public sector. Among the febrile patients, 
there was a very high prevalence of malaria positivity. 
This would appear somewhat discordant with the over-
all reduction in fever prevalence as observed in hospitals. 
Table 5 Perceptions and practices from the key health workers’ interviews on malaria rapid diagnostic use in the health 
facilities
Item assessed n Responses Percent (95 % CI)
Health facilities with knowledgeable health workers Correct knowledge
 Meaning of RDT 231 168 72.7 (67–78)
 What RDT assesses 232 196 81.7 (79–89)
 Specimen required 229 210 91.7 (87–95)
 Report ability to do test 223 160 71.7 (66–77)
Health facility mRDT practices by health workers Practice is yes
 Dedicated health worker for mRDT 184 125 67.9 (61–74)
 Use mRDT to determine treatment 186 137 73.7 (67–79)
 Use mRDT routinely 185 107 107 (52–66)
 Result available when treating patient 156 137 87.8 (82–92)
Perception in the health facilities on the use of mRDT Variable Favorable perception
 Useful for malaria diagnosis 166 132 79.5 (73–85)
 Takes short time 172 155 90.1 (85–94)
 Easy to conduct 131 126 96.2 (91–98)
 Does not interfere with clinic activities 129 122 94.6 (89–97)
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Considering that microscopy was the dominant means 
of diagnosis, this finding raises concern about its qual-
ity assurance. This observation may need further explo-
ration in studies that will focus significantly on quality 
assurance issues for malaria diagnosis in private health 
facilities. In the meanwhile, there might be the need for 
NMEP and RBM partners to strengthen quality assur-
ance in malaria diagnosis in private sector by ensuring 
compliance with the provision of implementation guide 
for parasite-based diagnosis of malaria in Nigeria. Cur-
rent findings will however suggest the need for more con-
certed outreach to formal private health facilities in order 
to improve their uptake of RDTs, especially given the 
challenges on quality assurance with malaria microscopy.
The high rate of test-before-treatment practice in the 
private facilities was also complimented by a high level of 
compliance to the result of the malaria test. This study’s 
composite measure of ‘compliance’ to appropriate treat-
ment with ACT following malaria test result was a high 
80.9  % (95  % CI 78.7–83.0  %), inclusive of those whose 
tests were negative and were not given ACT. The level 
of compliance was not affected by type of test or age of 
patients. There is virtually no parallel national study to 
compare this important finding with, except the NDHS 
household-based surveys reporting that 6.0 % of children 
under five with fever were appropriately given ACT, irre-
spective of test-result status or the health provider type 
[41]. ‘Compliance’ may also have been incentivised by 
the prospect of additional economic gain by prescrib-
ing a treatment, for a private establishment. However, 
as noted, the weighting of ‘compliance’ in this study also 
included not treating with ACT when the malaria test 
was negative. This balanced rational drug use is one of 
the cardinal indicators or measures of quality care. Sev-
eral studies have already reported the cost-effectiveness 
of the test-before-treatment policy in case management 
of malaria [33, 35–37, 56]. In this study, the cost of test 
was about $2.5 and this did not appear to be a disincen-
tive to the testing rate. Overall, 9.3 % of the clients had 
any form of medical insurance. It is, therefore, unlikely 
that insurance coverage will be an important explanation 
for the testing rate in spite of the cost of testing. A peculi-
arity within the Nigerian system is the general belief that 
laboratory testing is part of the evidence of the quality of 
care and may serve as a facilitator of willingness to pay. 
The authors postulate that this may the underlying factor 
behind the sustained high testing rate despite the cost of 
testing.
The spread of cadre of health workers reported in the 
present study is similar to that reported by Uzochukwu 
et al. [42]. Their study showed that awareness and knowl-
edge by health workers was higher among the public 
(72.2  %) than the private (50.0  %) health workers. The 
correct knowledge by over 70 % (range 71.7–91.7) of pri-
vate health workers reported in the present study was 
higher than the 61.1  % reported by Uzochukwu et  al. 
[42]. The reason for this could be attributed to training 
on RDT conducted by several non-governmental organi-
zations working in collaboration with the NMEP. These 
workers in the private health facilities reported a higher 
level of 79.5 % in the usefulness of RDT for malaria diag-
nosis than the 65.6 % health workers reported by the pre-
vious study [38].
The perception of the usefulness of RDT for malaria 
diagnosis and treatment among health workers in the 
private facilities was favourable. The perceived useful-
ness of the RDT test for diagnosis by the health workers 
in this study was 79.5 % (95 % CI 73–85 %) against 65.6 % 
previously reported [42]. Health workers’ opinion that 
RDT took a “short time” was consistently high with that 
reported by same authors [38]. These positive attitudes 
provide important opportunity for the scale up of RDT 
use in formal private health facilities with information 
targeted on addressing other areas of concerns that might 
limit their absolute confidence in the use of RDTs.
Regardless of the point of care, when health provid-
ers adhere to or comply with malaria test results, it is 
expected that there will be a lot of benefit to the health 
systems, the patients and the health facilities.
Conclusions
This study revealed an unprecedented report of the status 
of malaria testing rate, and compliance with malaria test 
results in private health facilities in Nigeria. In formal 
private health facilities in Nigeria, there is a high rate of 
malaria testing for febrile patients, high level of compli-
ance with test results but relatively low level of RDT utili-
zation. This calls for improved engagement of the formal 
private health sector with a view to achieving universal 
coverage targets on malaria testing.
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